Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 September 2019 | Story Ruan Bruwer | Photo Varsity Sports
Netball
Jana Scholtz, goal defender and playing in her first year as a regular starter, has been a solid performer for the Kovsie netball team in Varsity Netball.

The building blocks are starting to form a solid basis from where Kovsies can launch an attack to defend the Varsity Netball title they won in 2018. This is according to Karin Venter, one of the team’s assistant coaches.

After losing their first encounter to Tuks, they registered wins over the University of Johannesburg, Tshwane University of Technology, and the North-West University. The match against the Maties in Bloemfontein on 23 September 2019 – the last in the group stage, should determine which of the two teams will book a home semi-final along with Tuks.

“Yes, that is the crucial one,” said Venter, the team’s defensive coach. Her counterpart at the Maties is Adéle Niemand, with whom Venter combined as defenders at Kovsies for several matches in the mid-2000s. Apart from the Maties, the women of the University of the Free State still have to face the Madibaz and the University of the Western Cape (both in Pretoria on 15 and 16 September 2019).

“The combinations are starting to form a unit and our confidence is on the increase. Now we are looking for consistency in our performances.”

According to Venter, they were hit hard by goalkeeper Ané Retief’s injury, which kept her out of the first two matches. This meant that they had to start against Tuks with a first-year student, Chanel Vrey.

“It was tough, but I’m impressed with the way in which she, Ancia Pienaar, and Jana Scholtz – who are all youngsters – stepped up.”

Venter is responsible for the analyses and recons to assist players.

“The programme we are using provides us with all the required footage. You can make notes on it and send these clips to players, which means you don’t have to sit next to a player to explain something. We also provide them with notes and sketches of opponents’ playing patterns, which they must work through as part of their preparation.”

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept